The Latest Breaking News from Vaccine

The US Food and Drug Administration (FDA) has accepted for filing Krystal Biotech’s (NASDAQ:KRYS) Biologics License Application (BLA) for its lead candidate B-VEC in the treatment of patients with dystrophic epidermolysis bullosa (DEB). The regulatory agency has granted  Priority Review designation and assigned a target actin date of February 17,…

So Judge Jon Levy (D. Me.) held today in Lowe v. Mills. An excerpt: In this case, the amended complaint and the properly considered documents, information, and facts before me show that the purpose of requiring COVID-19 vaccinations for healthcare workers is solely to protect public health. Exempting individuals whose…

NHS England said people will be offered the next-generation bivalent vaccine where appropriate and subject to sufficient supply.

Moderna’s new dual-strain vaccine will be offered to millions of Britons ahead of winter

Firefighters’ spokesperson Eric Brocardi has said those refusing jab should remain suspended from job

Four UK Chief Medical Officers agreed vaccine deployment should be prioritised where there are localised outbreaks

The HSE says that 6,000 people are at heightened risk from the virus but the initial vaccine rollout will only be offered to 600 people

Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.

Vaccines helped neutralize the global threat of polio, a dreaded scourge that can cause paralysis and death, but that life-saving drug may have led unintentionally to the virus’ reappearance this year in the U.S. and other countries.